• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

通过计算机辅助图像系统分析乳腺癌中的Ki-67反应性：初步结果。

Ki-67 reactivity in breast carcinoma analyzed by a computer-assisted image system: preliminary results.

作者信息

Mir R, Johnson H, Mathur R, Wise L, Kahn L B

机构信息

Department of Pathology, Nassau County Medical Center, East Meadow, New York, USA.

出版信息

J Natl Med Assoc. 1995 Aug;87(8):554-9.

PMID:7674345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2607879/
Abstract

The proliferative index of 63 breast carcinomas was measured on Ki-67 immunostained frozen tissue sections with a computer-assisted image analysis system. The mean proliferative index in estrogen-positive breast carcinomas was lower than in estrogen-negative carcinomas. An inverse relationship between proliferative index and short-term disease-free survival was noted.

摘要

使用计算机辅助图像分析系统，在Ki-67免疫染色的冰冻组织切片上测量了63例乳腺癌的增殖指数。雌激素阳性乳腺癌的平均增殖指数低于雌激素阴性乳腺癌。观察到增殖指数与短期无病生存率之间呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac6/2607879/5a593b449679/jnma00397-0053-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac6/2607879/da75220beb1c/jnma00397-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac6/2607879/5a593b449679/jnma00397-0053-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac6/2607879/da75220beb1c/jnma00397-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac6/2607879/5a593b449679/jnma00397-0053-b.jpg

相似文献

1
Ki-67 reactivity in breast carcinoma analyzed by a computer-assisted image system: preliminary results.通过计算机辅助图像系统分析乳腺癌中的Ki-67反应性：初步结果。
J Natl Med Assoc. 1995 Aug;87(8):554-9.
2
Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.Ki-67和MIB-1增殖指数在乳腺癌中的比较预后价值
Anticancer Res. 1995 Nov-Dec;15(6B):2717-22.
3
PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.乳腺癌中PCNA/细胞周期蛋白的表达：其与Ki-67、雌激素受体、孕激素受体免疫染色及临床病理特征的关系
Pathologica. 1993 Jan-Feb;85(1095):47-55.
4
[Ki 67 growth fraction in carcinomas and benign lesions of the breast].[乳腺肿瘤及良性病变中的Ki-67增殖分数]
Zentralbl Pathol. 1993 Aug;139(3):201-5.
5
Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: a reproducibility study.使用CAS 200/486图像分析系统对浸润性乳腺癌进行定量免疫组织化学：一项重复性研究。
Anal Cell Pathol. 1995 Apr;8(3):227-45.
6
Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.原发性乳腺癌中通过Ki-67和增殖细胞核抗原（PCNA）免疫组织化学检测的生长分数与组织病理学参数及预后的相关性
Breast Cancer Res Treat. 1996;37(2):101-13. doi: 10.1007/BF01806492.
7
Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.使用新型“石蜡”反应性MIB1抗体研究乳腺癌中Ki-67抗原表达与有丝分裂指数及肿瘤分级的相关性。
Hum Pathol. 1994 Apr;25(4):337-42. doi: 10.1016/0046-8177(94)90140-6.
8
Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.乳腺癌中的表皮生长因子受体：定量免疫细胞化学检测与预后因素的相关性
Breast Cancer Res Treat. 1993;25(3):203-10. doi: 10.1007/BF00689834.
9
A comparison between Ki-67 antibody reactivity and other pathological variables in breast carcinoma.乳腺癌中Ki-67抗体反应性与其他病理变量的比较。
Pathology. 1991 Oct;23(4):282-5. doi: 10.3109/00313029109063589.
10
[Effect of the proliferation rate on the course of node negative breast carcinoma].[增殖率对淋巴结阴性乳腺癌病程的影响]
Geburtshilfe Frauenheilkd. 1995 Jun;55(6):299-305. doi: 10.1055/s-2007-1023323.

引用本文的文献

1
Usefulness of Ki-67, Mitoses, and Tumor Size for Predicting Metastasis in Carcinoid Tumors of the Lung: A Study of 48 Cases at a Tertiary Care Centre in Canada.Ki-67、有丝分裂及肿瘤大小对预测肺类癌转移的价值：加拿大一家三级护理中心48例病例研究
Lung Cancer Int. 2015;2015:545601. doi: 10.1155/2015/545601. Epub 2015 Dec 6.

本文引用的文献

1
Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy.未经治疗的乳腺癌的自然史（1805 - 1933年）。根据恶性组织学分级对未经治疗和经治疗的病例进行比较。
Br Med J. 1962 Jul 28;2(5299):213-21. doi: 10.1136/bmj.2.5299.213.
2
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons.女性乳腺癌的管理与生存情况：美国外科医师学会全国调查结果
Cancer. 1980 Jun 15;45(12):2917-24. doi: 10.1002/1097-0142(19800615)45:12<2917::aid-cncr2820451203>3.0.co;2-m.
3
Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival.
Cancer Res. 1980 Jun;40(6):1890-6.
4
Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor.乳腺癌的流式细胞术：II. 肿瘤细胞周期分布与组织学及雌激素受体的关系
Cancer. 1981 Aug 15;48(4):985-8. doi: 10.1002/1097-0142(19810815)48:4<985::aid-cncr2820480422>3.0.co;2-q.
5
Cell proliferation and its relationship to clinical features and relapse in breast cancers.
Cancer. 1981 Aug 15;48(4):974-9. doi: 10.1002/1097-0142(19810815)48:4<974::aid-cncr2820480420>3.0.co;2-#.
6
Kinetic parameters and the course of the disease in breast cancer.乳腺癌的动力学参数与疾病进程
Cancer. 1981 Mar 1;47(5):937-43. doi: 10.1002/1097-0142(19810301)47:5<937::aid-cncr2820470520>3.0.co;2-6.
7
Prediction of early course of breast carcinoma by thymidine labeling.通过胸腺嘧啶核苷标记预测乳腺癌的早期病程。
Cancer. 1983 May 15;51(10):1879-86. doi: 10.1002/1097-0142(19830515)51:10<1879::aid-cncr2820511021>3.0.co;2-9.
8
The long-term prognostic significance of the thymidine labelling index in breast cancer.乳腺癌中胸苷标记指数的长期预后意义。
Int J Cancer. 1984 Apr 15;33(4):441-5. doi: 10.1002/ijc.2910330404.
9
[Histomorphology of breast carcinoma and steroid receptor content].[乳腺癌的组织形态学与类固醇受体含量]
Pathologe. 1983 Nov;4(6):281-6.
10
Progesterone receptors as a prognostic factor in Stage II breast cancer.孕激素受体作为II期乳腺癌的一个预后因素
N Engl J Med. 1983 Dec 1;309(22):1343-7. doi: 10.1056/nejm198312013092240.